本页面由Tiger Trade Technology Pte. Ltd.提供服务

Fate Therapeutics Inc

2.00
-0.1300-6.10%
盘后:2.00-0.0028-0.14%16:20 EDT
成交量:95.25万
成交额:193.86万
市值:2.40亿
市盈率:-1.90
高:2.13
开:2.13
低:1.98
收:2.13
52周最高:3.23
52周最低:0.9500
股本:1.20亿
流通股本:1.05亿
量比:0.98
换手率:0.91%
股息:- -
股息率:- -
每股收益(TTM):-1.0528
每股收益(LYR):-1.1500
净资产收益率:-60.75%
总资产收益率:-26.22%
市净率:1.56
市盈率(LYR):-1.74

数据加载中...

2024/03/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/26

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/26

重要事件披露

Form 8-K - Current report
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/12

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/09

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/25

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/29

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/12/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/22

SEC问询函

Form CORRESP - Correspondence
2023/11/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/08

重要事件披露

Form 8-K - Current report
2023/11/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/08

重要事件披露

Form 8-K - Current report